(Q36765781)

16 August 2017

1 reference

title

New therapeutic strategies in the management of systemic sclerosis (English)

1 reference

16 August 2017

Yannick Allanore

1

1 reference

16 August 2017

Jèrôme Avouac

series ordinal

2

1 reference

16 August 2017

Julien Wipff

series ordinal

3

1 reference

16 August 2017

André Kahan

series ordinal

4

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 April 2007

1 reference

Expert Opinion on Pharmacotherapy

16 August 2017

published in

1 reference

16 August 2017

volume

8

1 reference

16 August 2017

issue

5

1 reference

16 August 2017

page(s)

607-615

1 reference

Genetics of scleroderma: update on single nucleotide polymorphism analysis and microarrays

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Antibodies against human cytomegalovirus in the pathogenesis of systemic sclerosis: a gene array approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: A model of scleroderma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Systemic sclerosis-associated Sjögren's syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Primary biliary cirrhosis (PBC)-CREST overlap syndrome with coexistence of Sjögren's syndrome and thyroid dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Radiological hand involvement in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Classification of systemic sclerosis. Visions and reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Mortality in systemic sclerosis: an international meta-analysis of individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

21 January 2018

Scleroderma renal crisis

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Clinical differences between idiopathic and scleroderma-related pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Systemic sclerosis associated pulmonary hypertension: improved survival in the current era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Sitaxsentan therapy for pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Sildenafil citrate therapy for pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Imatinib for the treatment of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Treatment of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Interstitial lung disease in scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Cyclophosphamide versus placebo in scleroderma lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Primary myocardial involvement in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Evaluation of the effect of nifedipine upon myocardial perfusion and contractility using cardiac magnetic resonance imaging and tissue Doppler echocardiography in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

A case-control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Prevalence of Barrett's esophagus in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Efficacy and tolerability of a selective alpha(2C)-adrenergic receptor blocker in recovery from cold-induced vasospasm in scleroderma patients: a single-center, double-blind, placebo-controlled, randomized crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.5.607

21 January 2018

Identifiers

DOI

10.1517/14656566.8.5.607

1 reference

16 August 2017

1 reference